Award-winning participants in the Department of Medicine’s second annual Research Day are studying diverse topics, including disease processes for atrial fibrillation; treatments for leukemia, diabetes and COPD; and the need for cortisol.
Contrary to physicians’ expectations, when patients with irritable bowel syndrome (IBS) rated their overall health, the severity of their symptoms played only a modest role in their assessments, a University at Buffalo study has found.
Award-winning participants in the Department of Medicine’s inaugural Research Day are studying diverse topics, including burnout, cold medications, a new-found anti-bacterial agent and a better leukemia treatment.
Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent treatment developed by a UB scientist achieved significant relief within four weeks.